SCHEMBL8813625

SCHEMBL8813625

CC(C)(C)CCCCCCCCCCCCO[C]=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL93123 1.00 HRH3 (0.31) HRH3
SCHEMBL3039788 1.00 HRH3 (0.31) HRH3
SCHEMBL2110013 1.00 HRH3 (0.31) HRH3
SCHEMBL2110891 1.00 HRH3 (0.31) HRH3
SCHEMBL2110280 1.00 HRH3 (0.31) HRH3
SCHEMBL2110940 1.00 HRH3 (0.31) HRH3
SCHEMBL2109675 1.00 HRH3 (0.31) HRH3
SCHEMBL93183 0.98 HRH3 (0.32) HRH3
SCHEMBL93139 0.91 HRH3 (0.30) HRH3
SCHEMBL7531856 0.81 FFAR1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5691319-A ANTICARCINOGENIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-11-25 US disclosed
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed